D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBP
2526
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $1.83M | ﹤0.01% |
+37,816
| New | +$2.05M |
|
|
CNSL
2527
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $1.83M | ﹤0.01% |
254,604
-25,346
| -9% | -$151K |
|
2528
CALL
Qorvo
QRVO
$8.09B
| $1.83M | ﹤0.01% |
10,000
-12,700
| -56% | -$2.23M |
|
|
FSKR
2529
DELISTED
FS KKR Capital Corp. II
FSKR
| $1.82M | ﹤0.01% |
+93,278
| New | +$1.69M |
|
2530
PJT Partners
PJT
$4.47B
| $1.82M | ﹤0.01% |
26,863
-12,269
| -31% | -$888K |
|
2531
CALL
Mastercard
MA
$497B
| $1.82M | ﹤0.01% |
5,100
-42,400
| -89% | -$14.8M |
|
2532
CALL
Tanger
SKT
$4.84B
| $1.82M | ﹤0.01% |
+120,000
| New | +$1.77M |
|
2533
PUT
AerCap
AER
$24.3B
| $1.81M | ﹤0.01% |
+30,900
| New | +$1.5M |
|
2534
PUT
Stratasys
SSYS
$690M
| $1.8M | ﹤0.01% |
69,500
+7,300
| +12% | +$252K |
|
|
GRUB
2535
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $1.8M | ﹤0.01% |
15,000
-3,500
| -19% | -$487K |
|
2536
CALL
Group 1 Automotive
GPI
$4.17B
| $1.8M | ﹤0.01% |
11,400
-11,600
| -50% | -$1.77M |
|
2537
Box
BOX
$4.36B
| $1.8M | ﹤0.01% |
78,253
-157,578
| -67% | -$3.07M |
|
|
ZEUS
2538
DELISTED
Olympic Steel
ZEUS
| $1.8M | ﹤0.01% |
61,031
-11,339
| -16% | -$220K |
|
|
CMRX
2539
DELISTED
Chimerix, Inc.
CMRX
| $1.79M | ﹤0.01% |
186,201
-311,479
| -63% | -$2.86M |
|
2540
PUT
Williams-Sonoma
WSM
$27.8B
| $1.79M | ﹤0.01% |
+20,000
| New | +$1.35M |
|
2541
PUT
Molson Coors Class B
TAP
$7.97B
| $1.79M | ﹤0.01% |
35,000
+5,000
| +17% | +$243K |
|
2542
CALL
Seagate
STX
$169B
| $1.79M | ﹤0.01% |
23,300
-600
| -3% | -$41.8K |
|
2543
OR Royalties Inc
OR
$5.52B
| $1.79M | ﹤0.01% |
162,167
-338,025
| -68% | -$3.86M |
|
|
GAP
2544
PUT
The Gap Inc
GAP
$7.28B
| $1.79M | ﹤0.01% |
60,000
-67,800
| -53% | -$1.69M |
|
2545
CALL
GSK
GSK
$108B
| $1.78M | ﹤0.01% |
+40,000
| New | +$1.82M |
|
|
TBA
2546
DELISTED
Thoma Bravo Advantage
TBA
| $1.78M | ﹤0.01% |
+170,535
| New | +$1.97M |
|
2547
CALL
MasTec
MTZ
$24.7B
| $1.78M | ﹤0.01% |
+19,000
| New | +$1.63M |
|
|
NFBK
2548
DELISTED
Northfield Bancorp
NFBK
| $1.78M | ﹤0.01% |
111,517
-10,268
| -8% | -$144K |
|
|
GOOD
2549
Gladstone Commercial Corp
GOOD
$627M
| $1.77M | ﹤0.01% |
90,776
-25,072
| -22% | -$474K |
|
2550
CRA International
CRAI
$1.16B
| $1.77M | ﹤0.01% |
23,739
+2,863
| +14% | +$174K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.